Cargando…
MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection
Aberrant levels of circulating miRNAs are potential biomarkers for the early detection of colorectal cancer (CRC). However, no previous systematic study has examined miRNAs in various specimen types from the same patient to evaluate their clinical utility. In this study, we compiled information from...
Autores principales: | Chang, Pi-Yueh, Chen, Chia-Chun, Chang, Yu-Sun, Tsai, Wen-Sy, You, Jeng-Fu, Lin, Geng-Ping, Chen, Ting-Wen, Chen, Jinn-Shiun, Chan, Err-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891149/ https://www.ncbi.nlm.nih.gov/pubmed/26848774 http://dx.doi.org/10.18632/oncotarget.7119 |
Ejemplares similares
-
MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue
por: Chuang, Tung-Yueh, et al.
Publicado: (2015) -
Evaluation of MicroRNA92, MicroRNA638 in Acute Lymphoblastic Leukemia of Egyptian Children
por: Fayed, Dina, et al.
Publicado: (2021) -
Role of MicroRNA-223 and MicroRNA-182 as Novel Biomarkers in Early Detection of Colorectal Cancer
por: Mahmoud, Hala A, et al.
Publicado: (2022) -
Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
por: Si, Haiyan, et al.
Publicado: (2012) -
MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients
por: Wang, Xiaomei, et al.
Publicado: (2017)